7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
about
Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility MappingUltrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease managementA gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imagingIs the Relationship between Cortical and White Matter Pathologic Changes in Multiple Sclerosis Spatially Specific? A Multimodal 7-T and 3-T MR Imaging Study with Surface and Tract-based Analysis.Down-regulation of interleukin 7 receptor (IL-7R) contributes to central nervous system demyelination.Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesionsContributions to magnetic susceptibility of brain tissue.Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple SclerosisBeyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7TDetection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple SclerosisThe association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7 T MRI.Insights from Ultrahigh Field Imaging in Multiple Sclerosis.Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.Heterogeneous pathological processes account for thalamic degeneration in multiple sclerosis: Insights from 7 T imaging.In Vivo 7T MR Quantitative Susceptibility Mapping Reveals Opposite Susceptibility Contrast between Cortical and White Matter Lesions in Multiple Sclerosis.Comparison of Routine Brain Imaging at 3 T and 7 T.Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosis.Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality.Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis.Key clinical benefits of neuroimaging at 7T.Assessment of cortical damage in early multiple sclerosis with quantitative T2 relaxometry.Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.Ultra-high-field (7.0 Tesla and above) MRI is now necessary to make the next step forward in understanding MS pathophysiology - YES.
P2860
Q26771174-D23C5F80-E6A3-4A41-BCB0-6A37FBEB8F9FQ26796643-73BD3F93-CE79-448B-B34B-2DE3D488712CQ28256984-FE6E28AA-CC1D-4512-9EAC-CBE035E1DAD6Q30991236-419564D8-A4B6-45C5-866D-6AEF30860040Q33709707-149C7DDB-FCF0-42D1-9B28-665ED018D233Q33841090-CBFF769B-7105-4DFE-BBB7-B5BEF02D1F22Q36033901-506ECFAA-12C7-4F12-99E9-F0C601E20E0FQ36204696-828AC350-7894-4438-AC2F-D0C01E97D530Q36300081-289A089D-7E46-4A2E-854C-00864E18BE26Q37004557-BEF7CC1A-2CCD-4837-A32B-6D3B0806D5ACQ37048758-CB57E1CF-1312-4ACF-98B2-BC0AC69E7989Q37172369-BB4B87B3-D2CC-485D-A4A8-CC00028ACD52Q37411407-4E420330-2AEC-4594-94E5-D2BCBC7AA5BEQ39229796-4E6E8BC4-34FF-46EF-9FEB-FDC8D0C397D6Q39937897-60F5D74B-D9EC-4A22-8C91-D8556DE8AE70Q42578096-C52A0D9B-433E-468A-A76D-A619E6569FD2Q46045619-89027A18-F658-445F-9B0A-9A594EC73522Q46147833-E20AE25A-0285-4285-8483-15FC1B869A06Q47146663-8159CB10-80FA-44D1-9823-E8D10CDDD49DQ47211664-F9A1A9BF-AD91-412A-9787-25E28CB34DEEQ47764071-7AF80FEF-BF7B-4C70-AEE1-FB877A8F7F27Q47989756-42DB33E3-F243-4646-B3F3-D6F732AC1320Q48276487-017EB009-91DE-41C4-8F1C-D3214251B7CBQ48428333-6E7D875E-ACE0-4CB6-9353-A36C9D0EA325Q48944544-BC1F18E3-1DA9-40EB-9638-E8D01E3F1E6AQ49142636-81AC1405-D907-4087-A31E-6167332B75ACQ53399890-2B81A9D2-04B0-4976-ACD0-B9B6790D5712Q54037056-84B4A1CB-94FF-4C9F-9C53-4186816D9BD1
P2860
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
@ast
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
@en
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
@nl
type
label
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
@ast
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
@en
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
@nl
prefLabel
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
@ast
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
@en
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
@nl
P2093
P2860
P1433
P1476
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
@en
P2093
Christina Chen
Francesca Bagnato
Hellmuth Merkle
Jeff H Duyn
Peter van Gelderen
Simon Hametner
P2860
P304
P356
10.1371/JOURNAL.PONE.0108863
P407
P577
2014-10-10T00:00:00Z